Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05790213
Title Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer
Recruitment Suspended
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Cincinnati
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UChicago Medicine Comprehensive Cancer Center Chicago Illinois 60637 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field